- Home
- ARVN vs WSBC Comparison
ARVN vs WSBC Comparison
Compare ARVN & WSBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARVN
- WSBC
- Stock Information
- Founded
- ARVN 2015
- WSBC 1870
- Country
- ARVN United States
- WSBC United States
- Employees
- ARVN N/A
- WSBC N/A
- Industry
- ARVN Biotechnology: Pharmaceutical Preparations
- WSBC Major Banks
- Sector
- ARVN Health Care
- WSBC Finance
- Exchange
- ARVN Nasdaq
- WSBC Nasdaq
- Market Cap
- ARVN 1.7B
- WSBC 1.8B
- IPO Year
- ARVN 2018
- WSBC N/A
- Fundamental
- Price
- ARVN $25.76
- WSBC $30.50
- Analyst Decision
- ARVN Strong Buy
- WSBC Hold
- Analyst Count
- ARVN 15
- WSBC 5
- Target Price
- ARVN $57.50
- WSBC $32.60
- AVG Volume (30 Days)
- ARVN 487.9K
- WSBC 306.9K
- Earning Date
- ARVN 10-30-2024
- WSBC 10-23-2024
- Dividend Yield
- ARVN N/A
- WSBC 4.72%
- EPS Growth
- ARVN N/A
- WSBC N/A
- EPS
- ARVN N/A
- WSBC 2.13
- Revenue
- ARVN $93,300,000.00
- WSBC $563,254,000.00
- Revenue This Year
- ARVN $179.49
- WSBC N/A
- Revenue Next Year
- ARVN N/A
- WSBC $68.20
- P/E Ratio
- ARVN N/A
- WSBC $14.34
- Revenue Growth
- ARVN N/A
- WSBC N/A
- 52 Week Low
- ARVN $13.57
- WSBC $23.00
- 52 Week High
- ARVN $53.08
- WSBC $34.85
- Technical
- Relative Strength Index (RSI)
- ARVN 50.68
- WSBC 51.76
- Support Level
- ARVN $25.42
- WSBC $28.76
- Resistance Level
- ARVN $29.24
- WSBC $31.95
- Average True Range (ATR)
- ARVN 1.24
- WSBC 0.67
- MACD
- ARVN 0.18
- WSBC 0.25
- Stochastic Oscillator
- ARVN 34.71
- WSBC 59.15
About ARVN Arvinas Inc.
Arvinas Inc is a United States-based biopharmaceutical company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development and commercialization of therapies that degrade disease-causing proteins.. The company's proprietary Proteolysis-Targeting Chimera (PROTAC), work by inducing the cell's own ubiquitin-proteasome system to target, degrade and remove disease-causing proteins. The group's product candidates are bavdegalutamide, ARV-471 and ARV-766.
About WSBC WesBanco Inc.
Wesbanco Inc is a bank holding company that offers a full range of financial services, including retail banking, corporate banking, personal and corporate trust services, brokerage services, mortgage banking, and insurance. The company has two reportable segments: community banking and trust and investment services. WesBanco operates one commercial bank, WesBanco Bank, which runs scores of branches. Its market service area primarily includes the Rust Belt region of the United States. Commercial real estate accounts for nearly half of the bank's loan portfolio. The bank has historically grown through both organic growth and acquisitions. The bank's primary component of net revenue is net interest income.